Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Examining Endothelial Function and Platelet Reactivity in Patients with Depression before and after SSRI Therapy

Bibliographic Data

ID15529417
AuthorsTye Dawood (Baker Heart and Diabetes Institute, corresponding author), David A Barton (Monash University), Élisabeth Lambert (0000-0002-2232-9048, Baker Heart and Diabetes Institute), Nina Eikelis (0000-0002-4001-1674, Baker Heart and Diabetes Institute), Gavin Lambert (0000-0003-0315-645X, Monash University)
Year2016
Volume7
Pages18-18
Publication date2016-02-18
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueFrontiers in Psychiatry (JOURNAL)
Journal identifiersISSN: 1664-0640 • E-ISSN: 1664-0640
PublisherFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2016.00018
PMID26924994
OpenAlexW2289355339
LanguageEN
References cited31

Although it is recognized that patients with major depressive disorder (MDD) are at increased risk of developing cardiovascular disease (CVD) the mechanisms responsible remain unknown. Endothelial dysfunction is one of the first signs of CVD. Using two techniques, flow-mediated dilatation in response to reactive hyperemia and laser Doppler velocimetry with iontophoresis, we examined endothelial function in the forearm before and after serotonin-specific reuptake inhibitor (SSRI) treatment in 31 patients with MDD. Measurement of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, soluble P-selectin, and noradrenaline in plasma was also performed. Prior to treatment, markers of endothelial and vascular function and platelet reactivity were within the normal range. Following SSRI therapy (95 ± 5 days) symptoms of depression were reduced (paired difference between pre- and post-treatment Hamilton rating -18 ± 1, P < 0.001) with 19 patients recovered and 4 remitted. There occurred no significant change in markers of endothelial or vascular function following SSRI therapy. The improvement in Hamilton depression rating in response to therapy could be independently predicted by the baseline arterial plasma noradrenaline concentration (r (2) = 0.36, P = 0.003). In this cohort of patients with MDD, SSRI therapy did not influence endothelial function or markers of vascular or platelet reactivity. Patient response to SSRI therapy could be predicted by the initial circulating level of noradrenaline, with noradrenaline levels being lower in responders

Depression (economics · Platelet · Psychiatry · Psychotherapist · Cardiac Health and Mental Health · Clinical Psychology · Medicine · Menopause: Health Impacts and Treatments · Psychology · Tryptophan and brain disorders · Internal Medicine

  • Association of Psychosocial Risk Factors With Risk of Acute Myocardial Infarction in 11 119 Cases and 13 648 Controls From 52 Countries (The Interheart Study)

    Open Access•Annika Rosengren, Steven Hawken et al.•The Lancet•2004

  • Plasma Nitrate Levels and Flow-Mediated Vasodilation in Untreated Major Depression

    Ronald G García, Juan G Zarruk et al.•Psychosomatic Medicine•2011

  • Associations Between Psychological Traits and Endothelial Function in Postmenopausal Women

    Kelly F Harris, Karen A Matthews et al.•Psychosomatic Medicine•2003

  • The relationship of soluble Icam-1, VCAM-1, P-selectin and E-selectin to cardiovascular disease risk factors in healthy men and women

    Open Access•Ellen W Demerath, E Demerath et al.•Annals of Human Biology•2001

Citation velocityhistorical
Highly citedNo

Tools

Open DOISci-HubOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae